HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Liu, M.-L. Articles by Yu, C.-K. Search for Related Content PubMed PubMed Citation Articles by Liu, M.-L. Articles by Yu, C.-K. Agricola Articles by Liu, M.-L. Articles by Yu, C.-K.

Type I interferons protect mice against enterovirus 71 infection

¹ Department of Microbiology & Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan 70101, Republic of China
² Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan 70101, Republic of China
³ Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, Taiwan 70101, Republic of China
⁴ Department of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan 70101, Republic of China
⁵ Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan 70101, Republic of China

Correspondence
Chun-Keung Yu
dckyu{at}mail.ncku.edu.tw

In this study, the contribution of type I interferons (IFNs) to protection against infection with enterovirus 71 (EV71) was investigated using a murine model where the virus was administrated to neonatal Institute of Cancer Research (ICR) mice by either the intraperitoneal (i.p.) or the oral route. In i.p. inoculated mice, post-infection treatment of dexamethasone (5 mg kg^–1 at 2 or 3 days after infection) exacerbated clinical symptoms and increased the tissue viral titre. In contrast, polyriboinosinic : polyribocytidylic acid [poly(I : C); 10 or 100 µg per mouse at 12 h before infection], a potent IFN inducer, improved the survival rate and decreased the tissue viral titres after EV71 challenge, which correlated with an increase in serum IFN- concentration, the percentage of dendritic cells, their expression of major histocompatibility complex class II molecule and IFN- in spleen. Treatment with a neutralizing antibody for type I IFNs (10⁴ neutralizing units per mouse, 6 h before and 12 h after infection) resulted in frequent deaths and higher tissue viral load in infected mice compared with control mice. In contrast, an early administration of recombinant mouse IFN-A (10⁴ U per mouse for 3 days starting at 0, 1 or 3 days after infection) protected the mice against EV71 infection. In vitro analysis of virus-induced death in three human cell lines showed that human type I IFNs exerted a direct protective effect on EV71. It was concluded that type I IFNs play an important role in controlling EV71 infection and replication.

This article has been cited by other articles:

				M. Arita, T. Wakita, and H. Shimizu Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity J. Gen. Virol., October 1, 2008; 89(10): 2518 - 2530. [Abstract] [Full Text] [PDF]

				M. Arita, Y. Ami, T. Wakita, and H. Shimizu Cooperative Effect of the Attenuation Determinants Derived from Poliovirus Sabin 1 Strain Is Essential for Attenuation of Enterovirus 71 in the NOD/SCID Mouse Infection Model J. Virol., February 15, 2008; 82(4): 1787 - 1797. [Abstract] [Full Text] [PDF]

				T.-C. Wu, Y.-F. Wang, Y.-P. Lee, J.-R. Wang, C.-C. Liu, S.-M. Wang, H.-Y. Lei, I.-J. Su, and C.-K. Yu Immunity to Avirulent Enterovirus 71 and Coxsackie A16 Virus Protects against Enterovirus 71 Infection in Mice J. Virol., October 1, 2007; 81(19): 10310 - 10315. [Abstract] [Full Text] [PDF]